Uniquely Conformed Peptide-Containing β2-Microglobulin- Free Heavy Chains of HLA-B2705 on the Cell Surface1
暂无分享,去创建一个
[1] V. Gnau,et al. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs , 2004, Immunogenetics.
[2] E. Camafeita,et al. The Cys-67 Residue of HLA-B27 Influences Cell Surface Stability, Peptide Specificity, and T-cell Antigen Presentation* , 2001, The Journal of Biological Chemistry.
[3] D. Rognan,et al. Mutation of Cys-67 Alters the Thermodynamic Stability of the Human Leukocyte Antigen HLA-B*2705* , 2001, The Journal of Biological Chemistry.
[4] S. Demaria,et al. Soluble HLA proteins with bound peptides are released from the cell surface by the membrane metalloproteinase. , 2000, Human immunology.
[5] D. Witte,et al. Development of spontaneous arthritis in beta2-microglobulin-deficient mice without expression of HLA-B27: association with deficiency of endogenous major histocompatibility complex class I expression. , 2000, Arthritis and rheumatism.
[6] C. Seitz,et al. Structurally diverse forms of HLA-B27 molecules are displayed in vivo in a cell type-dependent manner. , 2000, Human immunology.
[7] J. Strominger,et al. Perfusion chromatography for very rapid purification of class I and II MHC proteins. , 2000, Journal of immunological methods.
[8] N. Fernández,et al. Human major histocompatibility molecules have the intrinsic ability to form homotypic associations. , 1999, Human immunology.
[9] H. Rammensee,et al. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. , 1999, Journal of immunology.
[10] S. Demaria,et al. Peptide-conformed beta2m-free class I heavy chains are intermediates in generation of soluble HLA by the membrane-bound metalloproteinase. , 1999, Human immunology.
[11] A. McMichael,et al. The role of HLA-B27 in spondyloarthritis , 1999, Immunogenetics.
[12] R. Hammer,et al. Inflammatory disease in HLA‐B27 transgenic rats , 1999, Immunological reviews.
[13] J. Strominger,et al. Biotinylation of class I MHC molecules abrogates recognition by W6/32 antibody. , 1999, Tissue antigens.
[14] A. McMichael,et al. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. , 1999, Journal of immunology.
[15] C. López-Larrea,et al. The role of HLA-B27 polymorphism and molecular mimicry in spondylarthropathy. , 1998, Molecular medicine today.
[16] A. Rickinson,et al. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex. , 1998, Journal of immunology.
[17] H. Luthra,et al. HLA-B27 and other predisposing factors in spondyloarthropathies. , 1998, Current opinion in rheumatology.
[18] P. Cresswell,et al. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. , 1998, Immunity.
[19] H. Luthra,et al. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides. , 1998, Journal of immunology.
[20] H. Rammensee,et al. Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides. , 1997, Journal of immunology.
[21] R. Gibbs,et al. Large-scale concatenation cDNA sequencing. , 1997, Genome research.
[22] E Y Jones,et al. MHC class I and class II structures. , 1997, Current opinion in immunology.
[23] V. Engelhard,et al. Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies. , 1996, Journal of immunology.
[24] H. Luthra,et al. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies , 1995, The Journal of experimental medicine.
[25] D. Madden. The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.
[26] William Arbuthnot Sir Lane,et al. A subset of HLA-B27 molecules contains peptides much longer than nonamers. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Wang,et al. A monoclonal antibody that recognizes HLA-B27 in the context of peptides. , 1994, Journal of immunology.
[28] V. Engelhard,et al. Structure of peptides associated with class I and class II MHC molecules. , 1994, Annual review of immunology.
[29] Dean R. Madden,et al. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC , 1992, Cell.
[30] M. Bix,et al. Functionally conformed free class I heavy chains exist on the surface of beta 2 microglobulin negative cells , 1992, The Journal of experimental medicine.
[31] S. Demaria,et al. The origin and fate of β2m-free MHC class I molecules induced on activated T cells , 1992 .
[32] Maria L. Wei,et al. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides , 1992, Nature.
[33] P. Parham,et al. The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. , 1992, Journal of immunology.
[34] D. R. Madden,et al. Identification of self peptides bound to purified HLA-B27 , 1991, Nature.
[35] D. R. Madden,et al. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation , 1991, Nature.
[36] K. Rock,et al. Dissociation of β 2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface , 1991, Cell.
[37] D. Kwiatkowski,et al. HLA class I typing by PCR: HLA-B27 and an African B27 subtype , 1991, The Lancet.
[38] H. Ploegh,et al. HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. , 1990, International immunology.
[39] A. van Leeuwen,et al. Guilt by association: HLA-B27 and ankylosing spondylitis. , 1990, Immunology today.
[40] R. Demars,et al. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. , 1989, Journal of immunology.
[41] J. Strominger,et al. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. , 1987, The Journal of biological chemistry.
[42] J. Strominger,et al. Immunochemically purified DR antigens in liposomes stimulate xenogeneic cytolytic T cells in secondary in vitro cultures. , 1986, Cellular immunology.
[43] H. Ploegh,et al. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. , 1986, Journal of immunology.
[44] P. Cresswell,et al. Impaired assembly and transport of HLA‐A and ‐B antigens in a mutant TxB cell hybrid. , 1986, The EMBO journal.
[45] A. McMichael,et al. Recognition of HLA-B27 and related antigen by a monoclonal antibody. , 1982, Human immunology.
[46] P. Parham,et al. Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants. , 1982, Journal of immunology.
[47] W. Bodmer,et al. Characterization of a monoclonal anti‐β2‐microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens , 1979, European journal of immunology.
[48] C. Barnstable,et al. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. , 1979, Journal of immunology.
[49] C. Barnstable,et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.
[50] J. Strominger,et al. Submit and disulfide structure of monomeric and dimeric forms of detergent-soluble HLA antigens. , 1977, The Journal of biological chemistry.
[51] R D Sturrock,et al. Ankylosing spondylitis and HL-A 27. , 1973, Lancet.
[52] P I Terasaki,et al. High association of an HL-A antigen, W27, with ankylosing spondylitis. , 1973, The New England journal of medicine.
[53] T. Lund,et al. Ankylosing spondylitis and HLA-B27: restriction fragment length polymorphism and sequencing of an HLA-B27 allele from a patient with ankylosing spondylitis. , 1992, Annals of the rheumatic diseases.